.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Romana Höftberger

Vienna, AT

Medical University of Vienna

Speaker

13/09/2023
14:15 – 14:30 12 Min. 3 Min.
Invited Talk
S01-OT-T4
Neuroimmunology
14/09/2023
09:00 – 09:25 20 Min. 5 Min.
Invited Talk
S07-NI-T1
Neuropathology of autoimmune encephalitis

Further involvements

14/09/2023
ePoster
PS5-NI-A246
Iron handling in progressive MS
14/09/2023
ePoster
eP-ND-A219
Altered iron content in superficial and deep white matter in Alzheimer's Disease
14/09/2023
ePoster
eP-ND-A221
Histological methods to study spinal receptor expression after degeneration of descending tracts
14/09/2023
09:50 – 10:00 7 Min. 3 Min.
Abstract Talk
S07-NI-A230
Progressive Encephalomyelitis with Rigidity and Myoclonus with glycine receptor and GAD65 autoantibodies – clinico-pathological correlates and potential pathomechanisms of a rare disease
14/09/2023
13:21 – 13:27 4 Min. 2 Min.
ePoster Talk
PS5-NI-A246
Iron handling in progressive MS
15/09/2023
14:35 – 14:45 7 Min. 3 Min.
Abstract Talk
S21-NI-A236
Multifactorial white matter damage in the acute phase and pre-existing conditions may drive cognitive dysfunction after SARS-CoV-2 infection – neuropathology-based evidence